Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36

BACKGROUND & AIMS: Molecular mechanisms by which hypoxia might contribute to hepatosteatosis, the earliest stage in non‐alcoholic fatty liver disease (NAFLD) pathogenesis, remain still to be elucidated. We aimed to assess the impact of hypoxia‐inducible factor 2α (HIF2α) on the fatty acid transl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Liver Int
Main Authors: Rey, Esther, Meléndez‐Rodríguez, Florinda, Marañón, Patricia, Gil‐Valle, Miriam, Carrasco, Almudena G., Torres‐Capelli, Mar, Chávez, Stephania, del Pozo‐Maroto, Elvira, Rodríguez de Cía, Javier, Aragonés, Julián, García‐Monzón, Carmelo, González‐Rodríguez, Águeda
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Experimental Hepatology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539965/
https://ncbi.nlm.nih.gov/pubmed/32432822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14519
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki